Journal article
The Enzymes of the Rifamycin Antibiotic Resistome
Abstract
Rifamycin antibiotics include the WHO essential medicines rifampin, rifabutin, and rifapentine. These are semisynthetic derivatives of the natural product rifamycins, originally isolated from the soil bacterium Amycolatopsis rifamycinica. These antibiotics are primarily used to treat mycobacterial infections, including tuberculosis. Rifamycins act by binding to the β-subunit of bacterial RNA polymerase, inhibiting transcription, which results …
Authors
Surette MD; Spanogiannopoulos P; Wright GD
Journal
Accounts of Chemical Research, Vol. 54, No. 9, pp. 2065–2075
Publisher
American Chemical Society (ACS)
Publication Date
May 4, 2021
DOI
10.1021/acs.accounts.1c00048
ISSN
0001-4842